Hematology Probes Market Size, Share & Growth Analysis By Product (Chromosome Enumeration Probes, Microdeletion Probes, Preimplantation Probes), By End-User (Leukemia, Myeloma, Lymphoma, Other), And Regional Forecast, 2022-2028

Report Summary

Fluorescence in situ Hybridization (FISH) products for the effective and rapid identification of genetic aberrations associated with hematopoietic disorders. Used as single probes, or in multi-color probe sets, these products are designed to identify various chromosome translocations, deletions, chromosomal gains, as well as other rearrangements associated with specific hematopoietic disorders. These probes can be applied to a variety of sample types prepared for metaphase or interphase analysis. The global Hematology Probes market is valued at xx million US$ in 2020 and will reach xx million US$ by the end of 2027, growing at a CAGR of xx% during 2021-2027. The objectives of this study are to define, segment, and project the size of the Hematology Probes market based on company, product type, end user and key regions. This report studies the global market size of Hematology Probes in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hematology Probes in these regions. This research report categorizes the global Hematology Probes market by top players/brands, region, type and end user. This report also studies the global Hematology Probes market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The following manufacturers are covered in this report, with sales, revenue, market share for each company:

• Abbott
• ZytoVision
• Cytocell
• Abnova
• Creative Bioarray
• BioCat GmbH
• Empire Genomics
• GeneCopoeia
• MetaSystems Probes
• Generon
• Beijing ACCB Biotech Ltd

Hematology Probes Market, By Product

• Chromosome Enumeration Probes
• Microdeletion Probes
• Preimplantation Probes

Hematology Probes Market, By End-User

• Leukemia
• Myeloma
• Lymphoma
• Other

Market size by Region

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Singapore
  • Malaysia
  • Philippines
  • Thailand
  • Vietnam
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
• Central & South America
  • Brazil
  • Rest of Central & South America
• Middle East & Africa
  • GCC Countries
  • Turkey
  • Egypt
  • South Africa

The study objectives of this report are:

• To study and analyze the global Hematology Probes market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.
• To understand the structure of Hematology Probes market by identifying its various subsegments.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• Focuses on the key global Hematology Probes companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
• To project the value and sales volume of Hematology Probes submarkets, with respect to key regions.
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Hematology Probes are as follows: History Year: 2017-2020 Base Year: 2020 Estimated Year: 2020 Forecast Year 2021 to 2027 This report includes the estimation of market size for value (million US$) and volume (K Vials). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Hematology Probes market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table Of Contents

Table of Contents

1 Study Coverage
1.1 Hematology Probes Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Hematology Probes Market Size Growth Rate by Product
1.4.2 Chromosome Enumeration Probes
1.4.3 Microdeletion Probes
1.4.4 Preimplantation Probes
1.5 Market by End User
1.5.1 Global Hematology Probes Market Size Growth Rate by End User
1.5.2 Leukemia
1.5.3 Myeloma
1.5.4 Lymphoma
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Hematology Probes Market Size
2.1.1 Global Hematology Probes Revenue 2017-2027
2.1.2 Global Hematology Probes Sales 2017-2027
2.2 Hematology Probes Growth Rate by Regions
2.2.1 Global Hematology Probes Sales by Regions
2.2.2 Global Hematology Probes Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Hematology Probes Sales by Manufacturers
3.1.1 Hematology Probes Sales by Manufacturers
3.1.2 Hematology Probes Sales Market Share by Manufacturers
3.1.3 Global Hematology Probes Market Concentration Ratio (CR5 and HHI)
3.2 Hematology Probes Revenue by Manufacturers
3.2.1 Hematology Probes Revenue by Manufacturers (2017-2020)
3.2.2 Hematology Probes Revenue Share by Manufacturers (2017-2020)
3.3 Hematology Probes Price by Manufacturers
3.4 Hematology Probes Manufacturing Base Distribution, Product Types
3.4.1 Hematology Probes Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hematology Probes Product Type
3.4.3 Date of International Manufacturers Enter into Hematology Probes Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Hematology Probes Sales by Product
4.2 Global Hematology Probes Revenue by Product
4.3 Hematology Probes Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Hematology Probes Breakdown Data by End User

6 North America
6.1 North America Hematology Probes by Countries
6.1.1 North America Hematology Probes Sales by Countries
6.1.2 North America Hematology Probes Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Hematology Probes by Product
6.3 North America Hematology Probes by End User

7 Europe
7.1 Europe Hematology Probes by Countries
7.1.1 Europe Hematology Probes Sales by Countries
7.1.2 Europe Hematology Probes Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hematology Probes by Product
7.3 Europe Hematology Probes by End User

8 Asia Pacific
8.1 Asia Pacific Hematology Probes by Countries
8.1.1 Asia Pacific Hematology Probes Sales by Countries
8.1.2 Asia Pacific Hematology Probes Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Hematology Probes by Product
8.3 Asia Pacific Hematology Probes by End User

9 Central & South America
9.1 Central & South America Hematology Probes by Countries
9.1.1 Central & South America Hematology Probes Sales by Countries
9.1.2 Central & South America Hematology Probes Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Hematology Probes by Product
9.3 Central & South America Hematology Probes by End User

10 Middle East and Africa
10.1 Middle East and Africa Hematology Probes by Countries
10.1.1 Middle East and Africa Hematology Probes Sales by Countries
10.1.2 Middle East and Africa Hematology Probes Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Hematology Probes by Product
10.3 Middle East and Africa Hematology Probes by End User

11 Company Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Company Business Overview
11.1.3 Abbott Hematology Probes Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Abbott Hematology Probes Products Offered
11.1.5 Abbott Recent Development
11.2 ZytoVision
11.2.1 ZytoVision Company Details
11.2.2 Company Business Overview
11.2.3 ZytoVision Hematology Probes Sales, Revenue and Gross Margin (2017-2020)
11.2.4 ZytoVision Hematology Probes Products Offered
11.2.5 ZytoVision Recent Development
11.3 Cytocell
11.3.1 Cytocell Company Details
11.3.2 Company Business Overview
11.3.3 Cytocell Hematology Probes Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Cytocell Hematology Probes Products Offered
11.3.5 Cytocell Recent Development
11.4 Abnova
11.4.1 Abnova Company Details
11.4.2 Company Business Overview
11.4.3 Abnova Hematology Probes Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Abnova Hematology Probes Products Offered
11.4.5 Abnova Recent Development
11.5 Creative Bioarray
11.5.1 Creative Bioarray Company Details
11.5.2 Company Business Overview
11.5.3 Creative Bioarray Hematology Probes Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Creative Bioarray Hematology Probes Products Offered
11.5.5 Creative Bioarray Recent Development
11.6 BioCat GmbH
11.6.1 BioCat GmbH Company Details
11.6.2 Company Business Overview
11.6.3 BioCat GmbH Hematology Probes Sales, Revenue and Gross Margin (2017-2020)
11.6.4 BioCat GmbH Hematology Probes Products Offered
11.6.5 BioCat GmbH Recent Development
11.7 Empire Genomics
11.7.1 Empire Genomics Company Details
11.7.2 Company Business Overview
11.7.3 Empire Genomics Hematology Probes Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Empire Genomics Hematology Probes Products Offered
11.7.5 Empire Genomics Recent Development
11.8 GeneCopoeia
11.8.1 GeneCopoeia Company Details
11.8.2 Company Business Overview
11.8.3 GeneCopoeia Hematology Probes Sales, Revenue and Gross Margin (2017-2020)
11.8.4 GeneCopoeia Hematology Probes Products Offered
11.8.5 GeneCopoeia Recent Development
11.9 MetaSystems Probes
11.9.1 MetaSystems Probes Company Details
11.9.2 Company Business Overview
11.9.3 MetaSystems Probes Hematology Probes Sales, Revenue and Gross Margin (2017-2020)
11.9.4 MetaSystems Probes Hematology Probes Products Offered
11.9.5 MetaSystems Probes Recent Development
11.10 Generon
11.10.1 Generon Company Details
11.10.2 Company Business Overview
11.10.3 Generon Hematology Probes Sales, Revenue and Gross Margin (2017-2020)
11.10.4 Generon Hematology Probes Products Offered
11.10.5 Generon Recent Development
11.11 Beijing ACCB Biotech Ltd

12 Future Forecast
12.1 Hematology Probes Market Forecast by Regions
12.1.1 Global Hematology Probes Sales Forecast by Regions 2021-2027
12.1.2 Global Hematology Probes Revenue Forecast by Regions 2021-2027
12.2 Hematology Probes Market Forecast by Product
12.2.1 Global Hematology Probes Sales Forecast by Product 2021-2027
12.2.2 Global Hematology Probes Revenue Forecast by Product 2021-2027
12.3 Hematology Probes Market Forecast by End User
12.4 North America Hematology Probes Forecast
12.5 Europe Hematology Probes Forecast
12.6 Asia Pacific Hematology Probes Forecast
12.7 Central & South America Hematology Probes Forecast
12.8 Middle East and Africa Hematology Probes Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hematology Probes Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer